Rheinbay Esther, Parasuraman Prasanna, Grimsby Jonna, Tiao Grace, Engreitz Jesse M, Kim Jaegil, Lawrence Michael S, Taylor-Weiner Amaro, Rodriguez-Cuevas Sergio, Rosenberg Mara, Hess Julian, Stewart Chip, Maruvka Yosef E, Stojanov Petar, Cortes Maria L, Seepo Sara, Cibulskis Carrie, Tracy Adam, Pugh Trevor J, Lee Jesse, Zheng Zongli, Ellisen Leif W, Iafrate A John, Boehm Jesse S, Gabriel Stacey B, Meyerson Matthew, Golub Todd R, Baselga Jose, Hidalgo-Miranda Alfredo, Shioda Toshi, Bernards Andre, Lander Eric S, Getz Gad
The Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02124, USA.
Massachusetts General Hospital Center for Cancer Research, Charlestown, Massachusetts 02129, USA.
Nature. 2017 Jul 6;547(7661):55-60. doi: 10.1038/nature22992. Epub 2017 Jun 28.
Genomic analysis of tumours has led to the identification of hundreds of cancer genes on the basis of the presence of mutations in protein-coding regions. By contrast, much less is known about cancer-causing mutations in non-coding regions. Here we perform deep sequencing in 360 primary breast cancers and develop computational methods to identify significantly mutated promoters. Clear signals are found in the promoters of three genes. FOXA1, a known driver of hormone-receptor positive breast cancer, harbours a mutational hotspot in its promoter leading to overexpression through increased E2F binding. RMRP and NEAT1, two non-coding RNA genes, carry mutations that affect protein binding to their promoters and alter expression levels. Our study shows that promoter regions harbour recurrent mutations in cancer with functional consequences and that the mutations occur at similar frequencies as in coding regions. Power analyses indicate that more such regions remain to be discovered through deep sequencing of adequately sized cohorts of patients.
肿瘤的基因组分析已基于蛋白质编码区域中的突变鉴定出数百个癌症基因。相比之下,对于非编码区域中导致癌症的突变了解要少得多。在此,我们对360例原发性乳腺癌进行了深度测序,并开发了计算方法来识别显著突变的启动子。在三个基因的启动子中发现了明确的信号。FOXA1是激素受体阳性乳腺癌的已知驱动因子,其启动子中有一个突变热点,通过增加E2F结合导致过表达。RMRP和NEAT1这两个非编码RNA基因携带的突变会影响蛋白质与它们启动子的结合并改变表达水平。我们的研究表明,启动子区域在癌症中存在反复发生的具有功能后果的突变,且这些突变发生的频率与编码区域相似。功效分析表明,通过对足够规模的患者队列进行深度测序,还有更多这样的区域有待发现。